Deutsch English Français

Contact

EP2264126

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2264126

EP2264126 - Drug-delivery vehicles based on reversed liquid crystalline phase materials [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 03.05.2013 Database last updated on 02.11.2024
Most recent event Tooltip	03.05.2013	Withdrawal of application	published on 05.06.2013 [2013/23]
Applicant(s)	For all designated states Lyotropic Therapeutics, Inc. 10487 Lakeridge Parkway 400 Ashland, VA 23005 / US
	[2010/51]
Inventor(s)	01 / Anderson, David M. 13472 Lower Lakes Place 23005 Ashland / US
	02 / Cameransi, Benjamin G. 462 Lantana Circle SC 29440 Georgtown / US
	[2010/51]
Representative(s)	Kröncke, Rolf, et al Gramm, Lins & Partner Patent- und Rechtsanwälte PartGmbB Freundallee 13 a 30173 Hannover / DE
	[N/P]
Former [2010/51]	Kröncke, Rolf, et al Gramm, Lins & Partner Patent- und Rechtsanwaltssozietät GbR Freundallee 13a 30173 Hannover / DE
Application number, filing date	10011607.8	08.10.2004
	[2010/51]
Priority number, date	US20030509255P	08.10.2003 Original published format: US 509255 P
	US20040889313	13.07.2004 Original published format: US 889313
	[2010/51]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP2264126
	Date:	22.12.2010
	Language:	EN
	[2010/51]
	Type:	A3 Search report
	No.:	EP2264126
	Date:	28.11.2012
	Language:	EN
	[2012/48]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	30.10.2012
Classification	IPC:	C09K19/06, A61K9/14, A61K9/127, C09K19/02	[2012/48]
	CPC:	C09K19/02 (EP,US); A61K9/1274 (EP,US); A61P23/00 (EP); A61P23/02 (EP); A61P29/00 (EP); A61P35/00 (EP); (+) A61P37/04 (EP) (-)
	Former IPC [2010/51]	C09K19/06, A61K9/14
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2010/51]
Title	German:	Arzneimittelabgabeträgerstoff auf Basis von Umkehrphasenflüssigkristallmaterialien	[2010/51]
	English:	Drug-delivery vehicles based on reversed liquid crystalline phase materials	[2010/51]
	French:	Excipients pour administration de médicaments à base de matériaux à phase cristalline liquide inversée	[2010/51]
Examination procedure	30.09.2010	Examination requested [2010/51]
	25.04.2013	Application withdrawn by applicant [2013/23]
Parent application(s) Tooltip	EP04794515.9 / EP1677730
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040794515) is 07.10.2008
Fees paid	Renewal fee
	30.09.2010	Renewal fee patent year 03
	30.09.2010	Renewal fee patent year 04
	30.09.2010	Renewal fee patent year 05
	30.09.2010	Renewal fee patent year 06
	30.09.2010	Renewal fee patent year 07
	25.10.2011	Renewal fee patent year 08
	25.10.2012	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	WO9306921 [ ] (GS BIOCHEM AB [SE]) [ ] * claims 1-5,16-19 *;
		[XDI]US5531925 (LANDH TOMAS [SE], et al) [XD] 1,2,18 * column 14, lines 15-23 * * column 18, lines 50-56 * * claims 1-6,19-26 * [I] 3-17;
		[AD]US6071524 (RIBIER ALAIN [FR], et al) [AD] 1-18 * example -; claim - *;
		[AD]US2002153509 (LYNCH MATTHEW LAWRENCE [US], et al) [AD] 1-18* example -; claim - *;
		[AD]US6482517 (ANDERSON DAVID M [US]) [AD] 1-18 * columns 32-35 * * examples 2-14,17-33 * * claims 1-17 *;
		[X]WO03000236 (LYOTROPIC THERAPEUTICS INC [US]) [X] 1-18 * page 40, line 1 - page 45, line 13 * * page 46, line 19 - page 47, line 3 * * page 51, line 16 - page 59, line 3 * * page 65, line 31 - page 66, line 12 * * claims 1-6,10-19,27-32,41,42,46-54 *;
		[A]US2003108743 (ANDERSON DAVID M [US]) [A] 1-18 * example -; claim - *;
		[XP]WO03106589 (LYOTROPIC THERAPEUTICS INC [US]) [XP] 1-18 * pages 19-20 * * page 24, lines 4-26 * * claim - *
	by applicant	US5244799
		US5510118
		US5531925
		US5756108
		US6071524
		US2002153509
		US6482517
		US2003185873
		US6638621
		US6638537
		US6730698
		- Liquid Crystals & Plastic Crystals, ELLIS HORWOOD LTD., (1974), vol. 1, page 224
		- BALINOV; OLSSON; SODERMAN, J PHYS. CHEM., (1991), vol. 95, page 5931
		- LARSSON, J. PHYS. CHEM., (1989), vol. 93, no. 21, page 7304
		- J.R. KAMBAM; W.W. KINNEY; F. MATSUDA; W. WRIGHT; DA. HOLADAY, ANESTH. ANALG., (1990), vol. 70, no. 5, pages 543 - 5
		- W.W. KINNEY; J.R. KAMBAM; W. WRIGHT, CAN. J. ANAESTH., (1991), vol. 38, pages 533 - 6
		- S. OKA; M. MATSUMOTO; K. OHTAKE; T. KIYOSHIMA; K. NAKAKIMURA; T. SAKABE, ANESTH. ANALG., (2001), vol. 93, no. 4, pages 1050 - 7
		- A. WEBER; R. FOURNIER; E. VAN GESSEL; N. RIAND; Z. GAMULIN, ANESTH. ANALG., (2001), vol. 93, no. 5, pages 1327 - 31
		- G.J. GRANT; B. PISKOU; M. BANSINATH, CLIN. EXP. PHARM. PHYSIOL., (2003), vol. 30, page 966
		- GRANT ET AL., REGIONAL ANESTHESIA, (1994), vol. 19, no. 4, page 264
		- M.D. BLANCO ET AL., EUR. J. PHARM. BIOPHARM., (2003), vol. 55, page 229
		- D.B. MASTERS ET AL., PHARM. RES., (1993), vol. 10, page 1527
		- P. LECORRE ET AL., INT. J. PHARM., (1994), vol. 107, page 41
		- LAZARO ET AL., ANESTH. ANALG., (1999), vol. 89, page 121
		- LANGERMAN ET AL., ANESTHESIOLOGY, (1992), vol. 77, pages 475 - 81
		- E. LINDGREN; T. GREITZ, AM. J. EURORADIOLOGY, (1995), vol. 16, no. 2, pages 351 - 60
		- DYHRE ET AL., ACTA ANESTH. SCAND., (2001), vol. 45, no. 5, page 583
		- ANDERSON DM.; WENNERSTROM, H.; OLSSON, U., J PHYS. CHEM., (1989), vol. 93, pages 4532 - 4542
		- GUSTAFSSON; LJUSBERG-WAHREN; ALMGREN; LARSSON, LANGMUIR, (1996), vol. 12, no. 20, page 4611
		- NEMA, WASHKUHN; BRENDEL, PDAJ. OF PHARM. SCI. & TECHNOL., (1997), vol. 51, no. 4, page 166
		- R. LAUGHLIN, ADVANCES IN LIQUID CRYSTALS, (1978), pages 3 - 41
		- P. STROM; D-M. ANDERSON, LANGMUIR, (1992), vol. 8, pages 691 - 702
		- PELLE STROM; D. M. ANDERSON, LANGMUIR, (1992), vol. 8, page 691
		US20010994937
		US20020170214
		US20020387909
		US20020176112
		US20060460659

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p